Delivery Order SPE2DB22D2103-SPE2DB24FR9PY

Award Date 7/3/24
Potential Completion Date 7/25/24
Potential Value $6.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,375.85 Firm Fixed Price Delivery Order contract is for the supply of ORGOVYX 120 MG TABLET and has an ultimate completion date of December 17, 2024. Amerisourcebergen, as the prime contractor, has been awarded an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.52 firm fixed-price delivery order is for the drug ORGOVYX 120 MG TABLET, with a completion date of February 21, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $3,989.67 and is for the delivery of a pharmaceutical product, ORGOVYX 120 MG TABLET, with a delivery period ending on December 10, 2024. The contract is a firm fixed-price delivery order and is not set aside for any particular business type. Amerisourcebergen holds...
This federal contract award, valued at $1,329.89, was issued by the Medical Supply Chain division of the U.S. Defense agency to Amerisourcebergen Drug Corp's Corporate Office Division. The award is for the delivery of 4564677408 ORGOVYX 120 MG TABLET UU 30S, a pharmaceutical product. The contract has a completion date of June 12, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen, a major pharmaceutical distribution company, has an extensive Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $3,989.67, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to the Corporate Office of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4564801750 ORGOVYX 120 MG TABLET UU 30S, a prescription medication. This delivery order contract has a firm fixed-price pricing structure and a completion date of June 26, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,407.53, is for the delivery of ORGOVYX 120 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of October 16, 2023 and is a Firm Fixed Price Delivery Order with no set-aside designation. AmerisourceBergen holds a significant Indefinite...
This federal contract award is a Delivery Order from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,156.56, is for the supply of ORGOVYX 120 MG TABLET UU 30S, a pharmaceutical product. The contract has a Firm Fixed Price pricing type and has a period of performance through March 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,626.24 firm fixed-price delivery order contract is for the provision of ORGOVYX 120 MG TABLET medical supplies. The contract has a completion date of March 3, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award, valued at $1,375.85, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORGOVYX 120 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of January 22, 2025 and was awarded on December 30, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. AmerisourceBergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of the major pharmaceutical distributor Amerisourcebergen Corporation. The $1,329.89 Firm Fixed Price delivery order is for the provision of the prescription medication ORGOVYX 120 MG TABLET, with a period of performance through July 19, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
  • SPE2DB22D2103
    Indefinite Delivery Contract
  • SPE2DB22D2103-SPE2DB24FR9PY
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The $6,649.45 firm fixed-price delivery order is for the provision of 4565069495 - ORGOVYX 120 MG TABLET UU 30S, a pharmaceutical product, with a completion date of July 25, 2024.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award was made on a full and open competition basis without any set-aside designation.

Generated 10/2/24, 9:26 AM